<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04641338</url>
  </required_header>
  <id_info>
    <org_study_id>03/2020</org_study_id>
    <nct_id>NCT04641338</nct_id>
  </id_info>
  <brief_title>Fixed Combination of Dipirone and Codeine Compared to the Isolated Use of Dipyrone and Codeine in Controlling Pain After Pelvic-abdominal Surgery.</brief_title>
  <acronym>DIPICOR</acronym>
  <official_title>Randomized, Open, Multicentre, National Superiority Clinical Trial to Assess the Combination of Fixed Dosage of Dipyrone and Codeine Compared to the Isolated Use of Components in the Control of Moderate to Severe Pain After Open Pelvic-abdominal Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brazilian Clinical Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brainfarma Industria Química e Farmacêutica S/A</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Brazilian Clinical Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phase III clinical trial, multicentre of superiority, randomized, open, parallel groups, with&#xD;
      active control and use of postoperative oral medication (multiple doses of medication).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective is to evaluate the effectiveness and safety of the association in relation&#xD;
      to the isolated use of medicines.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average of sum of the pain difference</measure>
    <time_frame>During hospitalization (around 48 hours post surgical procedure)</time_frame>
    <description>The primary endpoint of the study is the average sum of the pain difference after study medication compared to the baseline by visual analogic scale from 0 to 10 cm, where 0 = no pain, and 10 = the worst imaginable pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average of visual analogic scale score</measure>
    <time_frame>During hospitalization (around 48 hours post surgical procedure)</time_frame>
    <description>The average visual analogic scale score (visual analogic scale from 0 to 10 cm, where 0 = no pain and 10 = the worst imaginable pain) measured at rest and during handling in subsequent medication.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VRS (verbal scale and relief assessment pain)</measure>
    <time_frame>During hospitalization (around 48 hours post surgical procedure)</time_frame>
    <description>VRS (verbal scale and relief assessment pain) where 0 = no pain relief, 1 = mild pain relief, 2 = moderate pain relief, 3 = good pain relief and 4 = excellent pain relief)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of complete pain relief by verbal scale and relief assessment pain (VRS)</measure>
    <time_frame>During hospitalization (around 48 hours post surgical procedure)</time_frame>
    <description>Assessment of complete pain relief by verbal scale assessment of pain relief (VRS where 0 = no pain relief, 1 = mild pain relief, 2 = moderate pain relief, 3 = good pain relief, and 4 = excellent pain relief).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for medication of rescue</measure>
    <time_frame>During hospitalization (around 48 hours post surgical procedure)</time_frame>
    <description>Number of patients who need medication of rescue (Patients who did not experience adequate pain relief with study medication who use additional analgesics, ie, rescue medication).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of satisfaction with treatment by the participant</measure>
    <time_frame>14 days</time_frame>
    <description>Assessment of satisfaction with treatment by the participant using a standard categorical rating scale: Patient-reported global evaluation of Eficacy (PGE) scale of 5-points where 0=poor, 1=fair, 2=good , 3=very good, and 5=excellent response to therapy).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of adverse events</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">328</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fixed dose combination Dipyrone and Codeine</intervention_name>
    <description>Fixed dose combination: dipyrone 1000 mg + codeine 30 mg every 6 hours if necessary.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dipyrone</intervention_name>
    <description>use of 1000 mg dipyrone every 6 hours if necessary.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Codeine</intervention_name>
    <description>30 mg codeine every 6 hours if necessary.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥ 18 years;&#xD;
&#xD;
          -  Patients in the 1st postoperative period of open abdominal or pelvic surgery (last 24&#xD;
             hours) and receiving short duration analgesics or opioids in any route of&#xD;
             administration on the previous day, being able to receive oral medication and&#xD;
             scheduled home discharge in hours or days, with pain moderate to intense intensity&#xD;
             (defined as VAS pain ≥ 4);&#xD;
&#xD;
          -  Have signed the informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Surgical complications to the inclusion of the participant in the research;&#xD;
&#xD;
          -  Other serious comorbidities at the discretion of the investigators (such as a history&#xD;
             of renal, hepatic, cardiac or other peptic ulcer);&#xD;
&#xD;
          -  History of chronic and current use of opioids or other analgesics;&#xD;
&#xD;
          -  Users of alcohol or illicit drugs;&#xD;
&#xD;
          -  Use of drugs with the potential to interact with study drugs;&#xD;
&#xD;
          -  Allergy, hypersensitivity or known contraindication to the use of components of the&#xD;
             study drug;&#xD;
&#xD;
          -  Psychiatric or social disorders that prevent adequate follow-up to the protocol;&#xD;
&#xD;
          -  Show inability to understand and perform current pain assessments in the study;&#xD;
&#xD;
          -  Women of childbearing potential, defined as all physiologically capable women of&#xD;
             childbearing, unless they are using effective contraceptive methods while&#xD;
             administering study medication;&#xD;
&#xD;
          -  Any clinical condition that the investigator considers to generate risk to the patient&#xD;
             or interfere with the conduct of the study;&#xD;
&#xD;
          -  Participation in another clinical study in less than a year (unless participation by&#xD;
             the principal investigator is justified).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Brainfarma Indústria Química Farmacêutica</last_name>
    <phone>5511 45072111</phone>
    <email>juliana.augusto@brainfarma.ind.br</email>
  </overall_contact>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 7, 2020</study_first_submitted>
  <study_first_submitted_qc>November 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 23, 2020</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dipirone</keyword>
  <keyword>Codeine</keyword>
  <keyword>pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dipyrone</mesh_term>
    <mesh_term>Codeine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

